12-2679587-C-T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_000719.7(CACNA1C):​c.5235C>T​(p.His1745His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000527 in 1,613,726 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.000079 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000050 ( 0 hom. )

Consequence

CACNA1C
NM_000719.7 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.384

Publications

0 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
ITFG2-AS1 (HGNC:53128): (ITFG2 antisense RNA 1)
CACNA1C-AS1 (HGNC:40119): (CACNA1C antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.4).
BP6
Variant 12-2679587-C-T is Benign according to our data. Variant chr12-2679587-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 190624.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.384 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAdExome4 allele frequency = 0.00005 (73/1461384) while in subpopulation AMR AF = 0.00123 (55/44680). AF 95% confidence interval is 0.000971. There are 0 homozygotes in GnomAdExome4. There are 31 alleles in the male GnomAdExome4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 12 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.5235C>T p.His1745His synonymous_variant Exon 42 of 47 ENST00000399655.6 NP_000710.5
CACNA1CNM_001167623.2 linkc.5235C>T p.His1745His synonymous_variant Exon 42 of 47 ENST00000399603.6 NP_001161095.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.5235C>T p.His1745His synonymous_variant Exon 42 of 47 5 NM_001167623.2 ENSP00000382512.1
CACNA1CENST00000399655.6 linkc.5235C>T p.His1745His synonymous_variant Exon 42 of 47 1 NM_000719.7 ENSP00000382563.1
CACNA1CENST00000682544.1 linkc.5469C>T p.His1823His synonymous_variant Exon 44 of 50 ENSP00000507184.1
CACNA1CENST00000406454.8 linkc.5235C>T p.His1745His synonymous_variant Exon 42 of 48 5 ENSP00000385896.3
CACNA1CENST00000399634.6 linkc.5202C>T p.His1734His synonymous_variant Exon 41 of 47 5 ENSP00000382542.2
CACNA1CENST00000683824.1 linkc.5400C>T p.His1800His synonymous_variant Exon 43 of 48 ENSP00000507867.1
CACNA1CENST00000347598.9 linkc.5379C>T p.His1793His synonymous_variant Exon 44 of 49 1 ENSP00000266376.6
CACNA1CENST00000344100.7 linkc.5358C>T p.His1786His synonymous_variant Exon 42 of 47 1 ENSP00000341092.3
CACNA1CENST00000327702.12 linkc.5235C>T p.His1745His synonymous_variant Exon 42 of 48 1 ENSP00000329877.7
CACNA1CENST00000399617.6 linkc.5235C>T p.His1745His synonymous_variant Exon 42 of 48 5 ENSP00000382526.1
CACNA1CENST00000682462.1 linkc.5325C>T p.His1775His synonymous_variant Exon 42 of 47 ENSP00000507105.1
CACNA1CENST00000683781.1 linkc.5325C>T p.His1775His synonymous_variant Exon 42 of 47 ENSP00000507434.1
CACNA1CENST00000683840.1 linkc.5325C>T p.His1775His synonymous_variant Exon 42 of 47 ENSP00000507612.1
CACNA1CENST00000683956.1 linkc.5325C>T p.His1775His synonymous_variant Exon 42 of 47 ENSP00000506882.1
CACNA1CENST00000399638.5 linkc.5319C>T p.His1773His synonymous_variant Exon 43 of 48 1 ENSP00000382547.1
CACNA1CENST00000335762.10 linkc.5310C>T p.His1770His synonymous_variant Exon 43 of 48 5 ENSP00000336982.5
CACNA1CENST00000399606.5 linkc.5295C>T p.His1765His synonymous_variant Exon 43 of 48 1 ENSP00000382515.1
CACNA1CENST00000399621.5 linkc.5292C>T p.His1764His synonymous_variant Exon 42 of 47 1 ENSP00000382530.1
CACNA1CENST00000399637.5 linkc.5292C>T p.His1764His synonymous_variant Exon 42 of 47 1 ENSP00000382546.1
CACNA1CENST00000402845.7 linkc.5292C>T p.His1764His synonymous_variant Exon 42 of 47 1 ENSP00000385724.3
CACNA1CENST00000399629.5 linkc.5286C>T p.His1762His synonymous_variant Exon 42 of 47 1 ENSP00000382537.1
CACNA1CENST00000682336.1 linkc.5277C>T p.His1759His synonymous_variant Exon 42 of 47 ENSP00000507898.1
CACNA1CENST00000399591.5 linkc.5259C>T p.His1753His synonymous_variant Exon 41 of 46 1 ENSP00000382500.1
CACNA1CENST00000399595.5 linkc.5259C>T p.His1753His synonymous_variant Exon 41 of 46 1 ENSP00000382504.1
CACNA1CENST00000399649.5 linkc.5253C>T p.His1751His synonymous_variant Exon 41 of 46 1 ENSP00000382557.1
CACNA1CENST00000399597.5 linkc.5235C>T p.His1745His synonymous_variant Exon 42 of 47 1 ENSP00000382506.1
CACNA1CENST00000399601.5 linkc.5235C>T p.His1745His synonymous_variant Exon 42 of 47 1 ENSP00000382510.1
CACNA1CENST00000399641.6 linkc.5235C>T p.His1745His synonymous_variant Exon 42 of 47 1 ENSP00000382549.1
CACNA1CENST00000399644.5 linkc.5235C>T p.His1745His synonymous_variant Exon 42 of 47 1 ENSP00000382552.1
CACNA1CENST00000682835.1 linkc.5235C>T p.His1745His synonymous_variant Exon 42 of 47 ENSP00000507282.1
CACNA1CENST00000683482.1 linkc.5226C>T p.His1742His synonymous_variant Exon 42 of 47 ENSP00000507169.1
CACNA1CENST00000682686.1 linkc.5202C>T p.His1734His synonymous_variant Exon 41 of 46 ENSP00000507309.1

Frequencies

GnomAD3 genomes
AF:
0.0000788
AC:
12
AN:
152224
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000524
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000238
AC:
59
AN:
247476
AF XY:
0.000201
show subpopulations
Gnomad AFR exome
AF:
0.000132
Gnomad AMR exome
AF:
0.00160
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000179
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000500
AC:
73
AN:
1461384
Hom.:
0
Cov.:
31
AF XY:
0.0000426
AC XY:
31
AN XY:
726958
show subpopulations
African (AFR)
AF:
0.0000598
AC:
2
AN:
33472
American (AMR)
AF:
0.00123
AC:
55
AN:
44680
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26108
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86192
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53362
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000144
AC:
16
AN:
1111760
Other (OTH)
AF:
0.00
AC:
0
AN:
60348
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
5
10
14
19
24
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000788
AC:
12
AN:
152342
Hom.:
0
Cov.:
33
AF XY:
0.0000805
AC XY:
6
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.0000721
AC:
3
AN:
41582
American (AMR)
AF:
0.000523
AC:
8
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68018
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.521
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.000181

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Sep 10, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Jan 27, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

CACNA1C-related disorder Benign:1
Jun 18, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
Oct 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CACNA1C: BP4, BP7, BS1 -

Long QT syndrome Benign:1
Nov 16, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Jan 25, 2017
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.40
CADD
Benign
7.0
DANN
Benign
0.84
PhyloP100
-0.38

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201861473; hg19: chr12-2788753; API